Ensuring Access to Generic Medications

Generic drugs offer treatment options that are as safe and effective as brand name drugs while also helping lower costs for both patients and health systems. It's estimated that over the last 10 years, generics have saved Americans $1.5 trillion. However, there are still many off-patent medications that have few or no generic alternatives. And even when generics do exist, there are instances where the generic receives steep price increases or experiences shortages.

During this podcast, we speak with Ron Piervincenzi, PhD, chief executive officer (CEO) of the United States Pharmacopeia, and Martin Van Trieste, CEO of Civica Rx, about these issues and what their companies are doing to address them.

You may need to log in to the website to access this podcast.

iTunes

TuneIn

Stitcher

Spotify

Listen above or through one of these podcast services:

Health Systems Move Forward in Establishing Nonprofit Generic Drug Company

Substituting Brand-Name Combinations for Generics Could Have Saved Medicare $925 Million in 2016

FDA Plan to Boost Drug Competition Includes Expedited Generic Approval Pathway

Costs for Seniors Jump as Generic Drugs Move to Higher Formulary Tiers in Part D Plans

Limited Distribution Networks Stifle Competition in the Generic and Biosimilar Drug Industries

To read more on generics: